Publications:

1. Shultz, M. D.; Ham, Y. W.; Lee, S.-G.; Davis, D.; Brown, C.; Chmielewski, J. Small Molecule Dimerization Inhibitors of Wild Type and Mutant HIV Protease: A Focused Library Approach. J. Am. Chem. Soc. 2004, 126(32), 9886-9887.

2. Ham, Y. W.; Boger, D. L. A Powerful Selection Assay for Mixture Libraries of DNA Alkylating Agents. J. Am. Chem. Soc. 2004, 126(30), 9194-9195.

3. Ham, Y. W.; Tse, W.; Boger, D. L. High Resolution Assessment of Protein DNA Binding Affinity and Selectivity Utilizing a Fluorescent Intercalator Displacement (FID) Assay. Bioorg. Med. Chem. Lett. 2003, 13(21), 3805-3807.

4. Issac, R.; Ham, Y. W.; Chmielewski, J. The design of self-replicating helical peptides. Curr. Opin. Struct. Biol. 2001, 11(4), 458-463.

5. Shultz, M. D.; Bowman, M. J.; Ham, Y. W.; Zhao, X.; Tora, G.; Chmielewski, J. Small-molecule inhibitors of HIV-1 protease dimerization derived from cross-linked interfacial peptides. Angew. Chem. Int. Ed. 2000, 39(15), 2710-2713.

6. Nam, K. H.; Oh, C. H.; Ham, Y. W.; Lee, K.S.; Cho, J. H. Synthesis and antibacterial activities of new 1b-methyl carbapenem having a 1,3-diazabicyclo[3.3.0]octan-2,4dione moiety. Archiv der Pharmazie. 1997, 330(8) 268-270.

7. Oh, C. H.; Ham, Y. W.; Hong, S.-Y.; Cho, J. H. Synthesis and antibacterial activities of new 1b-methyl carbapenem having a thiazolo[3,2-a]benzimidazole moiety. Archiv der Pharmazie. 1995, 328(3) 289-291.

Patents:

Reddy, G. R., Erathodiyil, N.; Ham, Y. W. Biodegradable polymer nanoparticles for therapeutic and diagnostic agents. PCT Int. Appl. (2006), 86 pp.